Citation: | JIN Shuanglong, WANG Fang, ZOU Yi, WANG Yan, HU Yue, GUO Wenjie, XU Qiang, LAI Yisheng. Design, synthesis and biological evaluation of phenylsulfonamide-based IDO1 inhibitors[J]. Journal of China Pharmaceutical University, 2018, 49(1): 34-38. DOI: 10.11665/j.issn.1000-5048.20180105 |
[1] |
Uyttenhove C,Pilotte L,Théate I,et al.Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase[J].Nat Med,2003,9(10):1269-1274.
|
[2] |
Platten M,von Knebel Doeberitz N,Oezen I,et al.Cancer immunotherapy by targeting IDO1/TDO and their downstream effectors[J].Front Immunol,2015,5:673.
|
[3] |
Cheng MF, Hung MS, Song JS, et al. Discovery and structure-activity relationships of phenyl benzenesulfonylhydrazides as novel indoleamine 2,3-dioxygenase inhibitors[J].Bioorg Med Chem Lett,2014,24(15):3403-3406.
|
[4] |
Nelson SD.Metabolic activation and drug toxicity[J].J Med Chem,1982,25(7):753-765.
|
[5] |
Zou Y,Wang F,WANG Y,et al.Discovery of imidazoleisoindole derivatives as potent IDO1 inhibitors:design,synthesis,biological evaluation and computational studies[J].Eur J Med Chem,2017,140:293-304.
|
[6] |
Jones G,Willett P,Glen RC,et al.Development and validation of a genetic algorithm for flexible docking[J].J Mol Biol,1997,267(3):727-748.
|